£∏q
∞ˇ

RW Malone, MD, LLC

Robert W. Malone, MD, MS

Physician Scientist -Licensed in Maryland

"From Bench to Bedside"

Premier Consulting Services

Your World is Our World

“In addition to being highly intelligent and exceptionally dedicated, Dr. Malone is readily able to identify key collaborators, build consensus, and mobilize teams to produce quality work. Dr. Malone is also generous with this expertise and experience, helping to equip, mentor, and connect those he works with. I heartily recommend him.”

Dr. Julie McMurry, Senior Project Manager, Vaccines and Therapeutics, Epivax, Inc.

“In addition to being one of the highest caliber vaccine experts that I have worked with in recent memory, Robert is a creative problem-solver and has a work ethic that matches, or exceeds, that of the normal EpiVax employee. And that is a compliment. We've enjoyed working with him and look forward to a long business relationship.” "Top qualities: Great Results, Expert, High Integrity”

Dr. Annie DeGroot, Founder and President, Epivax

“Robert provided consulting services for Aeras and functioned as Director, Business Development and Program Management. During this time Aeras profited both from his extraordinarily background in vaccine development and high skills in writing grants. Furthermore I had the privilege to get to know Robert on a personal basis; he is one of the very rare people I know that are able to pursue an extraordinarily scientific career while being a very down-to-earth and realistic individual.”

Stefanie Mueller, Research Specialist, Aeras Global TB Vaccine Foundation

“Robert was the Clinical Research Director of a cell-culture influenza vaccine program. His know-how, dedication, collaboration and communication skills are outstanding. I would welcome him back at any time.”

Dr. Daniel Becker, Global Safety Physician, Solvay Pharmaceuticals

“I have known Robert for many years as a collaborator on grants and contracts, as a science and business advisor, and as a colleague on the SAB at EpiVax, Inc. Robert is an easy person to work with, and has a wealth of working knowledge and experience in several key areas of biotechnology and pharma: immunology, molecular biology, vaccine product and clinical development, and IP expansion and management. On a personal level, Robert is an astute integrator of multiple and simultaneous inputs, an excellent trouble-shooter, and an enthusiastic physician-scientist who I respect and admire. He is a tireless worker with a stress-reducing sense of humor and a kind regard for people---truly a joy to work with.”

David Roth, PhD, Halozyme, Inc.

“As Clinical Research Director, Robert demonstrated in depth understanding the clinical development process. In the course of devising clinical development plans, Robert proactively highlights critical path issues and proposed approaches to mitigate risk,. He is a self-starter and demonstrates initiative as appropriate.”

Stephen Bell, Project Director, Solvay Pharmaceuticals

“I first met Robert over a year ago and have worked with him intensely over the last six weeks. He is a vaccine expert, both influenza and non-influenza. With a compelling personality, well developed interpersonal skills and a flexible approach, Robert can work effectively and successfully in any cultural environment.”

Larry Vaughn lvaughn@advantage-search.com, Senior Partner, Advantage ONE Executive Search

“Dr. Malone is extremely knowledgeable in his areas of expertise, is results-driven, and has sharp strategic eye for program development. Working with him at Solvay, in response to changing circumstances with regard to clinical supply, he recast the clinical and regulatory development plan and budget in a rapid and highly detailed manner. This plan allowed for the company's first US MDCK studies to begin just two months after IND clearance. He is an expert in translating cutting-edge pre-clinical stage biologic technologies into advanced clinical development. Furthermore, Dr. Malone was especially helpful in our strategic planning for the clinical and regulatory aspects of its US government (DHHS/BARDA) procurement initiatives; he is quite capable of propagating new funds/awards from a core program. A strong team player and consistent contributor and director, Dr. Malone is able to proactively understand a programs requirements, drive his and his team's energies to meet the needs of the overall program, deliver highly competitive ideas and solutions, and communicate progress accordingly. Dr. Malone would serve well as a CTO/CSO/CMO with a small and mid-size biotech company.”

Andrew Stevenson, MBA, Project Leader, Solvay Pharmaceuticals, Inc.

“Robert is a very knowledgeable and detail oriented individual capable of managing multiple project timelines to meet deliverables on-time.”

Tyrone Little, Manager, Regulatory Submissions and Information Services Summit Drug Development.

“Robert was the primary leader of the effort in the Department of Pathology to develop effective strategies to deliver exogenous DNA to cells in vivo. Robert was a leader in the field, and his research made important contributions in advancing our understanding of optimizing delivery of foreign genes into mammalian cells in vivo.”

Peter Barry, Professor, UC Davis

“I worked with Robert when I was a Senior Scientist at the Division of AIDS, NIAID, NIH from 1992-1999. At that time I was in charge of administering grants and contracts concerning adjuvants and nucleic acid vaccines for HIV vaccines. Robert is a talented molecular immunologist and has significantly contributed to gene vaccine delivery and the adjuvanting of DNA vaccines. His work while at UC Davis included research in cationic lipid mediated gene delivery - still today the most effective method for DNA vaccine delivery, research on mucosal immune responses to DNA vaccination, and methodology for the removal of contaminating endotoxin from DNA preparations. Robert not only possesses a high level of scientific expertise and mastery of his chosen fields of study, but is also highly personable with excellent communications skills. I highly recommend Robert Malone without reservation.”

Fred Vogel, Project Director, Sanofi Pasteur.

Copyright, 2008 Jill Glasspool Malone, PhD